Clinical Trial Evaluating Resminostat as Maintenance Therapy in CTCL Is Enrolling Participants
News
A Phase 2 trial is currently enrolling participants to evaluate 4SC‘s investigational therapy resminostat as a maintenance therapy for advanced-stage cutaneous T-cell lymphoma (CTCL). The RESMAIN study (NCT02953301) is being conducted at about ... Read more